← Back
▼ SELL 10b5-1 Plan

$ Value

$100K

Shares

1,348

Price

$74

Filed

Aug 27

Insider

Name

Noci Darlene

Title

Chief Development Officer

CIK

0001862148

Roles

Officer

Transaction Details

Transaction Date

2025-08-25

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

50,686

Footnotes

These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2024. | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.49 to $74.46, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (4) of this Form 4. | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.49 to $75.48, inclusive. | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.49 to $75.83, inclusive. | The shares underlying this option have vested or shall vest over the four years following January 6, 2023 in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.

Filing Info

Accession No.

0001862148-25-000005

Form Type

4

Issuer CIK

0001861560

Noci Darlene's History

Date Ticker Type Value
2026-03-30 NUVL M $153K
2026-03-30 NUVL $247K
2026-03-30 NUVL $291K
2026-03-30 NUVL M $0
2025-10-30 NUVL M $111K
2025-10-30 NUVL $6K
2025-10-30 NUVL $35K
2025-10-30 NUVL $119K
2025-10-30 NUVL $112K
2025-10-30 NUVL $116K

Other Insiders at NUVL (90d)

Insider Bought Sold Last
Balcom Alexandra
Chief Financial Officer
$3.7M 2026-04-01
Noci Darlene
Chief Development Officer
$538K 2026-03-30
Porter James Richard
President and CEO
$3.1M 2026-04-06
Miller Deborah Ann
Chief Legal Officer
$543K 2026-03-26
Pelish Henry E.
Chief Scientific Officer
$323K 2026-04-09
Lane Benjamin
See Remarks
2026-04-01